AI assistant
aTYR PHARMA INC — Director's Dealing 2015
May 6, 2015
34337_dirs_2015-05-06_342ea784-5bf8-4d7c-9726-035dc6960847.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: aTYR PHARMA INC (LIFE)
CIK: 0001339970
Period of Report: 2015-05-06
Reporting Person: Weiner David M. (Chief Medical Officer)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 5028 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (right to buy) | $4.06 | 2024-07-09 | Common Stock (115894) | Direct | |
| Stock Option (right to buy) | $9.15 | 2025-04-17 | Common Stock (31430) | Direct |
Footnotes
F1: 1/6th of the shares subject to this option shall vest and become exercisable on March 17, 2015 and the remaining shares subject to this option shall vest in 60 equal monthly installments beginning on March 17, 2015. This option is subject to accelerated vesting upon termination without cause upon a change of control of the Issuer.
F2: The shares subject to this option shall vest and become exercisable in 48 equal monthly installments beginning on April 17, 2015. This option is subject to accelerated vesting upon termination without cause upon a change of control of the Issuer.